SEC Form 4 · accession 0001645470-19-000012
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan Brian Collier
Officer — CEO
Period of report
Feb 14, 2019
Accepted (ET)
Feb 21, 2019 · 10:43 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 14, 2019 | P | 5,000 | $0.022 | A | 21,367,123 | D | |
| Common Stock | Feb 14, 2019 | P | 5,000 | $0.0219 | A | 21,372,123 | D | |
| Common Stock | Feb 14, 2019 | P | 5,000 | $0.0218 | A | 21,377,123 | D | |
| Common Stock | Feb 14, 2019 | P | 10,000 | $0.0219 | A | 21,387,123 | D | |
| Common Stock | Feb 14, 2019 | P | 10,000 | $0.0219 | A | 21,397,123 | D | |
| Common Stock | Feb 14, 2019 | P | 5,000 | $0.0218 | A | 21,402,123 | D | |
| Common Stock | Feb 14, 2019 | P | 5,000 | $0.0222 | A | 21,407,123 | D | |
| Common Stock | Feb 14, 2019 | P | 5,000 | $0.022 | A | 21,412,123 | D | |
| Common Stock | Feb 14, 2019 | P | 5,000 | $0.022 | A | 21,417,123 | D | |
| Common Stock | Feb 14, 2019 | P | 5,000 | $0.0222 | A | 21,422,123 | D | |
| Common Stock | Feb 15, 2019 | P | 5,000 | $0.0234 | A | 21,427,123 | D | |
| Common Stock | Feb 15, 2019 | P | 5,000 | $0.0234 | A | 21,432,123 | D | |
| Common Stock | Feb 15, 2019 | P | 5,000 | $0.0232 | A | 21,437,123 | D | |
| Common Stock | Feb 15, 2019 | P | 10,000 | $0.0233 | A | 21,447,123 | D | |
| Common Stock | Feb 15, 2019 | P | 5,000 | $0.0234 | A | 21,452,123 | D | |
| Common Stock | Feb 15, 2019 | P | 5,000 | $0.0227 | A | 21,457,123 | D | |
| Common Stock | Feb 15, 2019 | P | 5,000 | $0.0231 | A | 21,462,123 | D | |
| Common Stock | Feb 15, 2019 | P | 5,000 | $0.0234 | A | 21,467,123 | D | |
| Common Stock | Feb 15, 2019 | P | 5,000 | $0.0231 | A | 21,472,123 | D | |
| Common Stock | Feb 15, 2019 | P | 5,000 | $0.0231 | A | 21,477,123 | D | |
| Common Stock | Feb 15, 2019 | P | 5,000 | $0.0231 | A | 21,482,123 | D | |
| Common Stock | Feb 15, 2019 | P | 1,000 | $0.0233 | A | 21,483,123 | D | |
| Common Stock | Feb 15, 2019 | P | 1,000 | $0.0234 | A | 21,484,123 | D | |
| Common Stock | Feb 15, 2019 | P | 15,000 | $0.0223 | A | 21,499,123 | D | |
| Common Stock | Feb 15, 2019 | P | 10,000 | $0.0226 | A | 21,509,123 | D | |
| Common Stock | Feb 15, 2019 | P | 15,000 | $0.0228 | A | 21,524,123 | D | |
| Common Stock | Feb 15, 2019 | P | 10,000 | $0.0227 | A | 21,534,123 | D | |
| Common Stock | Feb 15, 2019 | P | 1,000 | $0.0227 | A | 21,535,123 | D | |
| Common Stock | Feb 15, 2019 | P | 1,000 | $0.0227 | A | 21,536,123 | D |
Table II — derivative securities
No Table II lines on this filing.